Anti-MOG autoantibody-associated schizophreniform psychosis

6Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

Objectives: Autoimmune mechanisms are related to disease development in a subgroup of patients with psychosis. The contribution of immunoglobulin G (IgG) antibodies against myelin oligodendrocyte glycoprotein (MOG) is mainly unclear in this context. Methods: Therefore, two patients with psychosis and anti-MOG antibodies – detected in fixed cell-based and live cell-based assays – are presented. Results: Patient 1 suffered from late-onset psychosis with singular white matter lesions in magnetic resonance imaging (MRI) and intermittent electroencephalography (EEG) slowing. Patient 2 suffered from a chronic paranoid–hallucinatory disorder with intermittent confusional states, non-specific white matter alterations on MRI, a disorganised alpha rhythm on EEG, and elevated cerebrospinal fluid protein. Both patients had anti-MOG antibody titres of 1: 320 in serum (reference < 1: 20). Conclusions: The arguments for and against a causal role for anti-MOG antibodies are discussed. The antibodies could be relevant, but due to moderate titres, they may have caused a rather ‘subtle clinical picture’ consisting of psychosis instead of ‘classical’ MOG encephalomyelitis.

Cite

CITATION STYLE

APA

von Zedtwitz, K., Matteit, I., Michel, M., Feige, B., Runge, K., Denzel, D., … Endres, D. (2022). Anti-MOG autoantibody-associated schizophreniform psychosis. Acta Neuropsychiatrica, 34(1), 47–54. https://doi.org/10.1017/neu.2021.29

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free